Alves, Raquel <br/><br/>
Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Feb 2019 
 - 30 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-019-1253-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Everolimus--administration & dosage<br/>Humans<br/>Imatinib Mesylate--administration & dosage<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive